Abstract
The goal of the biotransformation process is to develop structural changes and generate new chemical compounds, which can occur naturally in mammalian and microbial organisms, such as filamentous fungi, and represent a tool to achieve enhanced bioactive compounds. Cunninghamella spp. is among the fungal models most widely used in biotransformation processes at phase I and II reactions, mimicking the metabolism of drugs and xenobiotics in mammals and generating new molecules based on substances of natural and synthetic origin. Therefore, the goal of this review is to highlight the studies involving the biotransformation of Cunninghamella species between January 2015 and March 2021, in addition to updating existing studies to identify the similarities between the human metabolite and Cunninghamella patterns of active compounds, with related advantages and challenges, and providing new tools for further studies in this scope.
Keywords: Filamentous fungi, metabolism, chemical modifications, green chemical, cytochrome P450, xenobiotics.
Graphical Abstract
Current Drug Metabolism
Title:Recent Advances in Biotransformation by Cunninghamella Species
Volume: 22 Issue: 13
Author(s): Manoela Daiele Gonçalves*, Fernanda Tomiotto-Pellissier, Ricardo Luís Nascimento de Matos, João Paulo Assolini, Bruna Taciane da Silva Bortoleti, Virginia Marcia Concato, Taylon Felipe Silva, Janice Aparecida Rafael, Wander Rogério Pavanelli, Ivete Conchon-Costa and Nilton Syogo Arakawa
Affiliation:
- Laboratory of Biotransformation and Phytochemistry, Department of Chemistry, Center of Exact Sciences and Department of Pharmaceutical Sciences, Center of Health Sciences, State University of Londrina,Brazil
Keywords: Filamentous fungi, metabolism, chemical modifications, green chemical, cytochrome P450, xenobiotics.
Abstract: The goal of the biotransformation process is to develop structural changes and generate new chemical compounds, which can occur naturally in mammalian and microbial organisms, such as filamentous fungi, and represent a tool to achieve enhanced bioactive compounds. Cunninghamella spp. is among the fungal models most widely used in biotransformation processes at phase I and II reactions, mimicking the metabolism of drugs and xenobiotics in mammals and generating new molecules based on substances of natural and synthetic origin. Therefore, the goal of this review is to highlight the studies involving the biotransformation of Cunninghamella species between January 2015 and March 2021, in addition to updating existing studies to identify the similarities between the human metabolite and Cunninghamella patterns of active compounds, with related advantages and challenges, and providing new tools for further studies in this scope.
Export Options
About this article
Cite this article as:
Gonçalves Daiele Manoela *, Tomiotto-Pellissier Fernanda , de Matos Luís Nascimento Ricardo, Assolini Paulo João , da Silva Bortoleti Taciane Bruna, Concato Marcia Virginia, Silva Felipe Taylon , Rafael Aparecida Janice, Pavanelli Rogério Wander , Conchon-Costa Ivete and Arakawa Syogo Nilton , Recent Advances in Biotransformation by Cunninghamella Species, Current Drug Metabolism 2021; 22 (13) . https://dx.doi.org/10.2174/1389200222666211126100023
DOI https://dx.doi.org/10.2174/1389200222666211126100023 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Issues in the Psychiatric Screening of Cancer Patients
Current Psychiatry Reviews Interrelated Roles for the Aryl Hydrocarbon Receptor and Hypoxia Inducible Factor-1α in the Immune Response to Infection
Current Immunology Reviews (Discontinued) Clinical Approaches Toward Tumor Angiogenesis: Past, Present and Future
Current Pharmaceutical Design Viral Disorder or Disordered Viruses: Do Viral Proteins Possess Unique Features?
Protein & Peptide Letters Enzymes To Die For: Exploiting Nucleotide Metabolizing Enzymes for Cancer Gene Therapy
Current Gene Therapy Novel Nano Carriers for the Treatment of Progressive Auto Immune Disease Rheumatoid Arthritis
Current Pharmaceutical Design Valproic Acid in the Complex Therapy of Malignant Tumors
Current Drug Targets Targeting Telomerase for Cancer Therapy
Current Cancer Therapy Reviews Current Targets for Anticancer Drug Discovery
Current Drug Targets Cellular Reservoirs of HIV-1 and their Role in Viral Persistence
Current HIV Research A Review on Novel Breast Cancer Therapies: Photodynamic Therapy and Plant Derived Agent Induced Cell Death Mechanisms
Anti-Cancer Agents in Medicinal Chemistry Treatment Directed to Signalling Molecules in Patients with Advanced Differentiated Thyroid Cancer
Anti-Cancer Agents in Medicinal Chemistry Antibody Immobilization Techniques in Mass Sensitive Immunosensor: Enhanced Sensitivity through Limited Mass Load
Current Analytical Chemistry Perspectives for Novel Mixed Diruthenium-Organic Drugs as Metallopharmaceuticals in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry E2F1 and NF-κB: Key Mediators of Inflammation-associated Cancers and Potential Therapeutic Targets
Current Cancer Drug Targets Relationship Between Polymerase Gamma (POLG) Polymorphisms and Antiretroviral Therapy-Induced Lipodystrophy in HIV-1 Infected Patients: A Case-Control Study
Current HIV Research The Application of lncRNAs in Cancer Treatment and Diagnosis
Recent Patents on Anti-Cancer Drug Discovery The HAG Mechanism: A Molecular Rationale For The Therapeutic Application Of Iron Chelators In Human Diseases Involving the 2-Oxoacid Utilizing Dioxygenases
Current Medicinal Chemistry Electromagnetic Energy as a Bridge Between Atomic and Cellular Levels in the Genetics Approach to Cancer Treatment
Current Topics in Medicinal Chemistry Recent Advances in Antibody-Drug Conjugates for Breast Cancer Treatment
Current Medicinal Chemistry